April 25th 2025
The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.
What We’re Reading: Worker Heat Safety; COVID-19 Anxiety; Nursing Home Staffing Rule
September 5th 2023Rising temperatures demand action against heat-related illnesses; school superintendents face complex decisions as COVID-19 cases rise; national staffing standards for nursing homes present challenges.
Read More
CMS Releases List of 10 Drugs Subject to Price Negotiation Under IRA
August 29th 2023The 10 drugs, spanning disease states from diabetes to heart failure to rheumatoid arthritis, cost Medicare enrollees a total of $3.4 billion in out-of-pocket costs in 2022. As required by the Inflation Reduction Act (IRA), negotiations between Part D and pharmaceutical companies will take place this year and next, with the negotiated prices taking effect in 2026.
Read More
Patients and physicians are publicly shaming insurance companies on social media for the troublesome prior authorization process; HHS has awarded $1.4 billion in grants for the creation of new technologies and tools to prevent COVID-19 infection; Novo Nordisk has increased lobbying efforts to allow Medicare coverage of weight loss drugs.
Read More
What We’re Reading: Unpaid Medical Debt; COVID-19 and Hypertension; SNAP Work Requirement Changes
August 21st 2023About 17 million middle-class Americans have unpaid medical bills; more than 1 in 5 patients hospitalized with COVID-19 developed high blood pressure; work requirements for Supplemental Nutrition Assistance Program (SNAP) benefits to begin in September.
Read More
Patients with a specific gene are more likely to develop long COVID; senators send letters to the Internal Revenue Service, urging them to investigate the practices of nonpartisan hospitals; pregnant workers and workers with newborns could potentially gain job accommodations through a new proposal.
Read More
What We’re Reading: Heatstroke Calls Surge; Leqembi Update; Childhood Vaccination Rate Misses Target
August 7th 2023A severe heat wave is causing an uptick in heat-related emergency visits; Leqembi set to be rolled out in the coming months; declining childhood vaccination rate raises concerns over winter surge.
Read More
What We’re Reading: Historic Low of Uninsured; Youth Gender Treatments; Birth Control Recall
August 4th 2023A record low of 7.7% of Americans had no health insurance at the start of 2023; the American Academy of Pediatrics renewed its backing of gender care for children while requesting a research review; 2 lots of an oral contraceptive were recalled for possible reduction in effectiveness.
Read More
Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology
August 1st 2023Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."
Listen
Coverage of sessions on disparities in access to clinical trials and cancer screening, as well as relationships each to outcomes. A joint session presented by ASCO and the European Society for Medical Oncology (ESMO) highlighted progress and lingering gaps in lung and colorectal screening.
Read More
Intraparty disagreements over mifepristone cause pause in spending bill agreement until August recess ends; Officials urge the FDA to regulate cannabidiol as a dietary supplement; State medical boards tasked with protecting Americans frequently failed to stop doctors for COVID-19 misinformation.
Read More